【肺癌】《Cellworks》生物模擬平台準確預測「非小細胞肺癌」患者總生存期和化療獲益群

 【肺癌】《Cellworks》生物模擬平台準確預測「非小細胞肺癌」患者的總生存期和化療獲益患者群

 文章出處  

Businesswire 

 

 原文標題  

Cellworks Biosimulation Identifies which NSCLC Patients will Benefit from Combining Chemotherapy with Immunotherapy 

 

 Twitter  

https://x.com/aimedadviser/status/1835467133607878968 

 

 文章序號  

6263 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.